Home
About
Overview
Sharing Data
ORCID
Help
History (19)
MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Potential usefulness of biological fingerprints in chest radiographs for automated patient recognition and identification.
Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol. 2015 Sep 20; 33(27):3008-17.
View in:
PubMed
subject areas
Adolescent
Age of Onset
Child
Child, Preschool
Cooperative Behavior
Diffusion of Innovation
Humans
Infant
Infant, Newborn
Interdisciplinary Communication
International Cooperation
Medical Oncology
Neuroblastoma
Pediatrics
Predictive Value of Tests
Risk Assessment
Risk Factors
Survivors
Time Factors
Treatment Outcome
Young Adult
authors with profiles
Susan Cohn
Samuel Volchenboum
Mark Applebaum